Logo CICANCER

Old CIC Events

Antibody-Drug Conjugates Targeting EGFR in  Ovarian Cancer 30/06/2025

Antibody-Drug Conjugates Targeting EGFR in Ovarian Cancer

Sheila Almaraz — Centro de Investigación del Cáncer (Universidad de Salamanca - CSIC)

Structure of Centromeric Chromatin and Its Consequences for Genome Stability 19/06/2025

Structure of Centromeric Chromatin and Its Consequences for Genome Stability

Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)

Metabolic Control of Cell Fate in Regeneration and Cancer 16/06/2025

Metabolic Control of Cell Fate in Regeneration and Cancer

Almudena Chaves Pérez — Memorial Sloan Kettering Cancer Centre (NY)

defensa de tesis: Unraveling the role of RNA modifications in immune  evasion and tumor progression in prostate cancer 13/06/2025

defensa de tesis: Unraveling the role of RNA modifications in immune evasion and tumor progression in prostate cancer

Ana Macrina Añazco Guenkova — Programa de doctorado de biociencias: biología y clínica de cáncer

Dissecting metastatic Bladder Cancer 05/06/2025

Dissecting metastatic Bladder Cancer

Jesús M Paramio — CIEMAT and Inst Inv Biomed Univ Hosp “12 de Octubre”

Defining mechanisms of genomic evolution in cancer 29/05/2025

Defining mechanisms of genomic evolution in cancer

Sarah McClelland, PhD — Barts Cancer Institute, Queen Mary University of London

Alernativas a la carrera académica 27/05/2025

Alernativas a la carrera académica

María José Lallena, Macarena Algarín, Judith Anido —

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond 22/05/2025

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond

Carlos Fernández de Larrea — Hospital Clínic de Barcelona

Rational engineering of a bacteria for human lung therapy 15/05/2025

Rational engineering of a bacteria for human lung therapy

Luis Serrano — CRG. Barcelona

Preclinical and clinical evaluation of belantamab mafodotin based immunotherapy combinations in multiple myeloma 08/05/2025

Preclinical and clinical evaluation of belantamab mafodotin based immunotherapy combinations in multiple myeloma

Mauro Lorenzo Mohamed — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC

Tuning the ribosome in health and disease 24/04/2025

Tuning the ribosome in health and disease

Anders H. Lund — Biotech Research and Innovation Centre University of Copenhagen

Inherited and acquired genetic biomarkers in patients with Mast Cell Activation Syndromes and Mastocytosis 10/04/2025

Inherited and acquired genetic biomarkers in patients with Mast Cell Activation Syndromes and Mastocytosis

Paula Navarro — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC